Home > Inhibitors & Agonists > Metabolic Enzyme/Protease > Dipeptidyl Peptidase (DPP)
Cat. No. Product name CAS No.
DC11536 Imigliptin dihydrochloride

A novel potent, selective, orally available DPP-4 inhibitor with IC50 of 9 nM.

1314944-07-4
DC11897 Garvagliptin

A potent, selective dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment for type 2 diabetes..

1601479-87-1
DC11898 Gosogliptin

A potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM.

869490-23-3
DC11899 Gosogliptin dihydrochloride

A potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM.

869490-47-1
DC11723 AZD-7986

AZD-7986(INS-1007, AZD7986) is a highly potent, reversible, and selective DPP1 inhibitor with enzyme and cell pIC50 of 8.4.

1802148-05-5
DC8108 DBPR108

DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9. IC50 value: 15 Nm.

1186426-66-3
DC1105 Linagliptin (BI-1356) Featured

Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.

668270-12-0
DC7585 MK-3102(Omarigliptin) Featured

MK-3102 (MSD) is a novel DPP-4 Inhibitor, which improves glycaemic control with low risk of symptomatic hypoglycaemia.

1226781-44-7
DC8875 Saxagliptin

Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM and Ki of 1.3 nM.

361442-04-8
DC8739 Talabostat mesylate

Talabostat mesilate(PT-100; Val-boroPro) is an orally active, specific inhibitor of dipeptidyl peptidases(IC50=1 nM for DPP4), including tumor-associated fibroblast activation protein.

150080-09-4
DC28139 Dutogliptin tartrate

Dutogliptin tartrate (PHX-1149) is an orally available, potent, and selective dipeptidyl peptidase-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus.

890402-81-0
DC28358 1G244

1G244 is a potent DPP8/9 inhibitor with IC50s of 12 nM and 84 nM, respectively. 1G244 does not inhibit DPPIV and DPPII. 1G244 induces apoptosis in multiple myeloma cells and has anti-myeloma effects.

847928-32-9
DC28382 Evogliptin tartrate

Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity. Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation.

1222102-51-3
Page 1 / Total 1 FirstPrevNextLastGoto